These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 30165426

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Incidence of Acute Kidney Injury Among Patients Receiving the Combination of Vancomycin with Piperacillin-Tazobactam or Meropenem.
    Robertson AD, Li C, Hammond DA, Dickey TA.
    Pharmacotherapy; 2018 Dec; 38(12):1184-1193. PubMed ID: 30175410
    [Abstract] [Full Text] [Related]

  • 3. Vancomycin With Concomitant Piperacillin/Tazobactam vs. Cefepime or Meropenem Associated Acute Kidney Injury in General Ward Patients: A Multicenter Propensity Score-Matched Study.
    Komerdelj IA, Buckley MS, D'Alessio PA, Ziadat DS, Kobic E, Rangan P, Agarwal SK, Tinta NC, Yerondopoulos MJ, Kane-Gill SL.
    J Pharm Pract; 2024 Feb; 37(1):80-87. PubMed ID: 36075000
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Vancomycin with concomitant piperacillin/tazobactam vs. cefepime or meropenem associated acute kidney injury in the critically ill: A multicenter propensity score-matched study.
    Buckley MS, Komerdelj IA, D'Alessio PA, Rangan P, Agarwal SK, Tinta NC, Martinez BK, Ziadat DS, Yerondopoulos MJ, Kobic E, Kane-Gill SL.
    J Crit Care; 2022 Feb; 67():134-140. PubMed ID: 34768175
    [Abstract] [Full Text] [Related]

  • 8. Incidence of Acute Kidney Injury among Patients Treated with Piperacillin-Tazobactam or Meropenem in Combination with Vancomycin.
    Rutter WC, Burgess DS.
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712661
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the Nephrotoxicity of Vancomycin in Combination With Cefepime, Meropenem, or Piperacillin/Tazobactam: A Prospective, Multicenter Study.
    Mullins BP, Kramer CJ, Bartel BJ, Catlin JS, Gilder RE.
    Ann Pharmacother; 2018 Jul; 52(7):639-644. PubMed ID: 29442542
    [Abstract] [Full Text] [Related]

  • 10. [Risk of Acute Kidney Injury in Patients Treated with Vancomycin and Piperacillin/Tazobactam Compared to Vancomycin and Meropenem or Doripenem: A Retrospective Cohort Study].
    Ide N, Sato S, Sawaguchi K.
    Yakugaku Zasshi; 2019 Jul; 139(12):1609-1614. PubMed ID: 31787651
    [Abstract] [Full Text] [Related]

  • 11. Comparative Prevalence of Acute Kidney Injury in Chinese Patients Receiving Vancomycin with Concurrent β-Lactam Antibiotics: A Retrospective Cohort Study.
    Liu K, Zhang Y, Xu X, Wu B, Ni J, Li T, Xing C, Mao H.
    Clin Ther; 2021 Oct; 43(10):e319-e351. PubMed ID: 34579971
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of teicoplanin versus vancomycin in combination with piperacillin-tazobactam or meropenem for the risk of acute kidney injury.
    Aslan AT, Pashayev T, Dağ O, Akova M.
    Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1953-1961. PubMed ID: 33884515
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The Risk of Acute Kidney Injury in Critically Ill Patients Receiving Concomitant Vancomycin With Piperacillin-Tazobactam or Cefepime.
    Molina KC, Barletta JF, Hall ST, Yazdani C, Huang V.
    J Intensive Care Med; 2020 Dec; 35(12):1434-1438. PubMed ID: 30741072
    [Abstract] [Full Text] [Related]

  • 17. Piperacillin/Tazobactam and Antibiotic-Associated Acute Kidney Injury in Critically Ill Children.
    Joyce EL, Kane-Gill SL, Priyanka P, Fuhrman DY, Kellum JA.
    J Am Soc Nephrol; 2019 Nov; 30(11):2243-2251. PubMed ID: 31501354
    [Abstract] [Full Text] [Related]

  • 18. Retrospective Cohort Study of the Incidence of Acute Kidney Injury with Vancomycin Area under the Curve-Based Dosing with Concomitant Piperacillin-Tazobactam Compared to Meropenem or Cefepime.
    Kiley PS, Pearston AP, Hodge LA, Kaplan MC, Baczek SM, Stanley JS, Wilson TJ, Soriano KM, Yao A, Shaeffer ZA, Talt IE, Cohen JA, Ingemi AI.
    Antimicrob Agents Chemother; 2022 Aug 16; 66(8):e0004022. PubMed ID: 35867523
    [Abstract] [Full Text] [Related]

  • 19. Risk of Acute Kidney Injury and Clostridioides difficile Infection With Piperacillin/Tazobactam, Cefepime, and Meropenem With or Without Vancomycin.
    Lee JD, Heintz BH, Mosher HJ, Livorsi DJ, Egge JA, Lund BC.
    Clin Infect Dis; 2021 Oct 05; 73(7):e1579-e1586. PubMed ID: 33382398
    [Abstract] [Full Text] [Related]

  • 20. Acute kidney injury following the concurrent administration of antipseudomonal β-lactams and vancomycin: a network meta-analysis.
    Bellos I, Karageorgiou V, Pergialiotis V, Perrea DN.
    Clin Microbiol Infect; 2020 Jun 05; 26(6):696-705. PubMed ID: 32222460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.